## Abstract ## BACKGROUND The endogenous opioid peptide, [Met^5^]βenkephalin, termed opioid growth factor (OGF), interacts with its receptor (OGFr) to play a role as a constitutively expressed inhibitory growth factor in the proliferation of epithelial cells. This study compared protein and gene e
β¦ LIBER β¦
Opioid growth factor (OGF) inhibits the progression of human squamous cell carcinoma of the head and neck transplanted into nude mice
β Scribed by Patricia J. McLaughlin; Roger J. Levin; Ian S. Zagon
- Book ID
- 117467881
- Publisher
- Elsevier Science
- Year
- 2003
- Tongue
- English
- Weight
- 210 KB
- Volume
- 199
- Category
- Article
- ISSN
- 0304-3835
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Defects in the opioid growth factor rece
β
Patricia J. McLaughlin; Brendan C. Stack Jr.; Roger J. Levin; Fred Fedok; Ian S.
π
Article
π
2003
π
John Wiley and Sons
π
English
β 541 KB
Opioid growth factor enhances tumor grow
β
Jeffrey R. Jaglowski; Ian S. Zagon; Brendan C. Stack; Michael F. Verderame; Alph
π
Article
π
2005
π
Springer
π
English
β 257 KB
Antisense inhibition of vascular endothe
β
Torahiko Nakashima; J. Michael Hudson; Gary L. Clayman
π
Article
π
2000
π
John Wiley and Sons
π
English
β 202 KB
π 2 views
Changes in growth pattern of human squam
β
Johan Wennerberg
π
Article
π
1984
π
John Wiley and Sons
π
French
β 494 KB
The role of epidermal growth factor rece
β
Rebecca G. Pomerantz; Jennifer Rubin Grandis
π
Article
π
2003
π
Current Science Inc.
π
English
β 537 KB
Epidermal growth factor receptor targete
β
Mark E. Sharafinski; Robert L. Ferris; Soldano Ferrone; Jennifer R. Grandis
π
Article
π
2010
π
John Wiley and Sons
π
English
β 382 KB
π 2 views
## Abstract ## Background Cumulative evidence implicates the epidermal growth factor receptor (EGFR) as an important therapeutic target in head and neck squamous cell carcinoma (HNSCC). The basis for the lack of correlation between EGFR expression in the HNSCC tumor and clinical responses to EGFR